A new analysis finds considerable disparities in survival correlation to race and socio-economic status among patients with head and neck cancer. Reported in the November 15, 2008 issue of CANCER, a peer-evaluated journal of the American Cancer Society, the study indicates that earlier diagnosis and greater access to therapy could improve outcomes for these cancers among African Americans and the poor........

Modern cancer care is critically dependent on imaging technologies, which are used to detect early tumors and guide their therapy or surgery. Molecular imaging technologies provide information about the functional or metabolic characteristics of malignancies, tumor stage and therapeutical response, and tumor recurrence; whereas conventional imaging technologies predominantly assess the tumor's anatomical or morphologic features including its size, density, shape, etc........

Boston Patients who are treated with proton treatment (a specialized type of external beam radiation treatment using protons rather than X-rays to treat cancer) decreases the risk of patients developing a secondary cancer by two hundred percent, in comparison to being treated with standard photon radiation therapy, as per a first-of-its-kind study presented September 22, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston........

Advances in understanding head and neck cancer over the last decade have led to more therapy options and improved quality of life for patients, as per a review published this week in the New England Journal (NEJM) The authors are Dong M. Shin, MD, Frances Kelly Blomeyer Distinguished Professor and associate director of Emory University School of Medicines Winship Cancer Institute, and Robert Haddad, MD, assistant professor of medicine at Harvard Medical School and clinical director of its Head and Neck Oncology Program........

The absence or inactivation of the RUNX3 gatekeeper gene paves the way for the growth and development of colon cancer, Singapore researchers report in the Sept. issue of the journal Cancer Cell Prior studies have shown that RUNX3 plays a role in gastric, breast, lung and bladder cancers. The inactivation of RUNX3 occurs at a very early stage of colon cancer, as per the Singapore scientists' studies with human tissue samples and animal models........

One-fifth of British adult survivors of childhood cancers are current smokers, and nearly a third have been regular smokers at some point in their lives, as per a research studyin the July 29 online issue of the Journal of the National Cancer Institute Adult survivors of childhood cancer are at increased risk of developing cardiovascular disease, lung problems, and second malignancies, relative to the general public. These increased risks are due to long-term effects of the original cancer and its therapy, as well as to genetic conditions that predispose the survivors to multiple cancers. Smoking would be an additional source of risk for this population........

A study performed by scientists at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Instituto de Biologa Molecular of the CSIC, reveal a mechanism that controls the movement of cells in a tissue by regulating cell adhesion. This same mechanism may be defective in diseases such as cancer and its metastasis, when tumour cells lose their adhesion to neighbouring cells and migrate through the organism. The results of this research have been published in this week's Nature Cell Biology.......

Scientists at Rhode Island Hospital have identified two potential molecular markers that may predict outcomes for patients with stomach cancer, one of the most common and fatal cancers worldwide. As per the study, reported in the July 1 issue of Clinical Cancer Research, patients who had poor outcomes following surgery for stomach cancer also had extremely low amounts of two proteins, known as gastrokine 1 and 2 (GKN1 and GKN2), which are produced by normal stomach cells........

Early laboratory research has shown that resveratrol, a common dietary supplement, suppresses the abnormal cell formation that leads to most types of breast cancer, suggesting a potential role for the agent in breast cancer prevention. Resveratrol is a natural substance found in red wine and red grapes. It is sold in extract form as a dietary supplement at most major drug stores........

Cancer starts when key cellular signals run amok, driving uncontrolled cell growth. But researchers at the Stanford University School of Medicine report that lowering levels of one cancer signal under a specific threshold reverses this process in mice, returning tumor cells to their normal, healthy state. The finding could help target cancer chemotherapy to tumors while minimizing side effects for the body's healthy cells........

Eating one or more portions of broccoli every week can reduce the risk of prostate cancer, and the risk of localised cancer becoming more aggressive. For the first time, a research group at the Institute of Food Research led by Professor Richard Mithen has provided an explanation of how eating broccoli might reduce cancer risk based upon studies in men, as opposed to trying to extrapolate from animal models. Prostate cancer is the most common non-skin cancer for males in western countries. The research has provided an insight into why eating broccoli can help men stay healthy........

A simple blood test may help doctors better predict whether prostate cancer will recur or spread in patients who have undergone surgery for the disease, UT Southwestern Medical Center scientists have found. As per a research findings reported in the June 15 issue of Clinical Cancer Research, UT Southwestern researchers identified a panel of seven biomarkers that can predict with 86 percent accuracy which patients with prostate cancer will experience a recurrence and progression of the disease. Biomarkers are proteins circulating in a patient's blood that are specific to a disease........

Researchers at the Institute of Food Research have detected subtle changes that may make the bowel more vulnerable to the development of tumours. With support from the Food Standards Agency and the Biotechnology and Biological Sciences Research Council they are investigating whether diet could control these changes and delay or reverse the onset of cancer........

HOUSTON - Efforts to protect the tumor-suppressor p53 could just as easily shelter a mutant version of the protein, causing cancer cells to thrive and spread rather than die, as per research by researchers at The University of Texas M. D. Anderson Cancer Center published in the current issue of the journal Genes and Development........

OHSU pancreas cancer expert Brett Sheppard, M.D., and his colleagues in the OHSU Oregon Stem Cell Center, have developed antibodies that recognize pancreas cancer; Sheppard is presenting these findings this week during Digestive Disease Week in San Diego. This week scientists in the Oregon Health and Science University (OHSU) Oregon Stem Cell Center and the OHSU Digestive Health Center are shining a new ray of hope on patients with pancreas cancer. They've developed new reagents, or antibodies, that can recognize this often lethal disease. This important discovery may one day lead to earlier detection and therapy........

A poster session presented today by The University of Texas M. D. Anderson Cancer Center at the Oncology Nurses Society 33rd Annual Congress, observed that early nursing intervention and implementation of effective strategies can lead to a decrease in the occurence rate of lymphedema, better management of chronic lymphedema and improved quality of life in patients with breast cancer........

While researching new ways to stop the progression of cancer, scientists at the University of Oklahoma Health Sciences Center, have discovered a compound that has shown to prevent cancer in the laboratory. The compound, which still faces several rounds of clinical trials, successfully stopped normal cells from turning into cancer cells and inhibited the ability of tumors to grow and form blood vessels. If proved to be successful tests continue, scientists eventually hope to create a daily pill that would be taken as a cancer preventive........